BESSEMER GROUP INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2022$6,000
+20.0%
1600.0%0.00%
Q4 2021$5,000
+25.0%
1600.0%0.00%
Q3 2021$4,000
-33.3%
1600.0%0.00%
Q2 2021$6,000
-14.3%
1600.0%0.00%
Q1 2021$7,000
-68.2%
160
-68.0%
0.00%
Q4 2020$22,000
-38.9%
500
-23.1%
0.00%
Q3 2020$36,000
-42.9%
650
-35.0%
0.00%
Q2 2020$63,000
-95.9%
1,000
-98.0%
0.00%
-100.0%
Q3 2017$1,553,000
+13.5%
50,0090.0%0.01%0.0%
Q2 2017$1,368,000
+308.4%
50,009
+115.9%
0.01%
+200.0%
Q4 2016$335,00023,1600.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 383,702$14,581,0007.71%
Perceptive Advisors 5,148,910$195,658,0005.23%
Grace Capital 312,514$11,876,0004.65%
NEXTHERA CAPITAL LP 549,231$20,871,0004.00%
Asymmetry Capital Management, L.P. 103,449$3,931,0003.63%
Camber Capital Management LP 2,075,000$78,850,0003.37%
Casdin Capital, LLC 440,000$16,720,0002.03%
EMORY UNIVERSITY 53,951$2,050,0001.34%
ArchPoint Investors 129,435$4,919,0001.34%
Ghost Tree Capital, LLC 150,000$5,700,0001.21%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders